Regulated cell adhesion is critical for most immune functions. Integrins are one of the more important families of adhesion molecules, and Lymphocyte Function-Associated Antigen-1 (LFA-1) is the most abundant beta2 integrin. The purpose of this proposal is to examine the regulatory mechanisms of LFA-1 adhesiveness for intercellular Adhesion Molecule 1 (ICAM-1). Cells expressing constitutively active or non- active LFA-1 will be prepared by retroviral mutagenesis and selected for the desired phenotype. This type of mutagenesis links a phenotype (active or non-active LFA-1) to the genotype. Thus, a gene that has been disrupted by a retrovirus and causes a particular phenotype can be identified. Understanding how lymphocytes regulate adhesion will lead to new therapeutic strategies for controlling inflammation and possibly autoimmune diseases and the rejection of organ transplants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AR008632-02
Application #
6446850
Study Section
Special Emphasis Panel (ZRG1-IMB (01))
Program Officer
Gretz, Elizabeth
Project Start
2001-09-01
Project End
Budget Start
2001-09-01
Budget End
2001-11-30
Support Year
2
Fiscal Year
2001
Total Cost
$11,299
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Cherry, Lisa K; Li, Xiaoyu; Schwab, Pascale et al. (2004) RhoH is required to maintain the integrin LFA-1 in a nonadhesive state on lymphocytes. Nat Immunol 5:961-7